Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating CC-122

NCT05688475 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT05688475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating CC-122
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 11, 2023
Completion date
October 31, 2026
Enrollment
12 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma